Wen-Song Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wen-Song Yang has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Qi Li
The Second Affiliated Hospital of Anhui Medical University
8 shared publications - Peng Xie
NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
6 shared publications Peng Xie
5 shared publicationsYong-Bo Ma
The First Affiliated Hospital of Chongqing Medical University
4 shared publicationsShu-Qiang Zhang
Chongqing University Fuling Hospital
3 shared publicationsXiao Hu
3 shared publications
Latest Publications
- Open Access
Inflammatory Biomarkers and Interpretable Machine Learning Model for Stroke-Associated Pneumonia Risk Stratification in Patients Undergoing Bridging Therapy for Acute Ischemic Stroke
Stroke-associated pneumonia (SAP) is a major complication affecting the prognosis of acute ischemic stroke (AIS) patients who undergo intravenous thrombolysis followed by bridging mechanical thrombectomy (MT). Existing predictive tools are mostly subjective, and the value of combined biomarkers and interpretable machine learning (ML) models in this specific population remains unclear. This study aimed to construct an interpretable ML model to predict SAP risk in AIS patients undergoing bridging therapy, and to identify key predictive factors using Shapley Additive Explanations (SHAP). A single-center retrospective observational study was conducted on 135 AIS patients who received intravenous thrombolysis followed by bridging MT at Xinxiang Central Hospital from January 2019 to December 2023. Clinical data, laboratory indicators (including neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyte ratio [PLR], systemic immune-inflammation index [SII], and systemic inflammatory response index [SIRI]) were collected. LASSO regression was used for feature selection, and ten ML models were constructed to predict SAP. The optimal model was selected based on area under the receiver operating characteristic curve (AUC-ROC) and decision curve analysis (DCA), and SHAP analysis was applied to interpret the model. Among 135 included patients, 70 (51.9%) developed SAP. LASSO regression selected 11 key variables associated with SAP. The CatBoost model showed the best performance, with an AUC of 0.952 in the training set and 0.932 in the test set. SHAP analysis revealed that the 7-day National Institutes of Health Stroke Scale (NIHSS_7d), 24-h SIRI (SIRI_24h), and 24-h white blood cell count (WBC_24h) were the top three factors contributing to SAP prediction. Dynamic detection showed that 24-h and 48-h NLR, 24-h SII, and 24-h and 48-h SIRI were significantly higher in the SAP group than in the non-SAP group (all P < 0.05), while no significant difference in PLR was observed between the two groups. Inflammatory biomarkers (24-h NLR, 24-h SII, 24-h SIRI, 48-h NLR, 48-h SIRI) are closely associated with SAP in AIS patients undergoing bridging therapy. The interpretable CatBoost model constructed with LASSO-selected variables exhibits high predictive value for SAP, which can help clinicians identify high-risk patients early and guide personalized treatment.
Open AccessInflammatory Biomarkers and Interpretable Machine Learning Model for Stroke-Associated Pneumonia Risk Stratification in Patients Undergoing Bridging Therapy for Acute Ischemic Stroke
Stroke-associated pneumonia (SAP) is a major complication affecting the prognosis of acute ischemic stroke (AIS) patients who undergo intravenous thrombolysis followed by bridging mechanical thrombectomy (MT). Existing predictive tools are mostly subjective, and the value of combined biomarkers and interpretable machine learning (ML) models in this specific population remains unclear. This study aimed to construct an interpretable ML model to predict SAP risk in AIS patients undergoing bridging therapy, and to identify key predictive factors using Shapley Additive Explanations (SHAP). A single-center retrospective observational study was conducted on 135 AIS patients who received intravenous thrombolysis followed by bridging MT at Xinxiang Central Hospital from January 2019 to December 2023. Clinical data, laboratory indicators (including neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyte ratio [PLR], systemic immune-inflammation index [SII], and systemic inflammatory response index [SIRI]) were collected. LASSO regression was used for feature selection, and ten ML models were constructed to predict SAP. The optimal model was selected based on area under the receiver operating characteristic curve (AUC-ROC) and decision curve analysis (DCA), and SHAP analysis was applied to interpret the model. Among 135 included patients, 70 (51.9%) developed SAP. LASSO regression selected 11 key variables associated with SAP. The CatBoost model showed the best performance, with an AUC of 0.952 in the training set and 0.932 in the test set. SHAP analysis revealed that the 7-day National Institutes of Health Stroke Scale (NIHSS_7d), 24-h SIRI (SIRI_24h), and 24-h white blood cell count (WBC_24h) were the top three factors contributing to SAP prediction. Dynamic detection showed that 24-h and 48-h NLR, 24-h SII, and 24-h and 48-h SIRI were significantly higher in the SAP group than in the non-SAP group (all P < 0.05), while no significant difference in PLR was observed between the two groups. Inflammatory biomarkers (24-h NLR, 24-h SII, 24-h SIRI, 48-h NLR, 48-h SIRI) are closely associated with SAP in AIS patients undergoing bridging therapy. The interpretable CatBoost model constructed with LASSO-selected variables exhibits high predictive value for SAP, which can help clinicians identify high-risk patients early and guide personalized treatment.
- Open Access
- 1 February 2026
- Published by KEAI Publishing in Brain Hemorrhages
- Vol. 7 (1) , 49-55
Research progress on risk stratification warning models for early hematoma expansion and poor outcome in intracerebral hemorrhage: A narrative review
- 1 February 2026
- Published by KEAI Publishing in Brain Hemorrhages
- Vol. 7 (1) , 49-55
Open AccessResearch progress on risk stratification warning models for early hematoma expansion and poor outcome in intracerebral hemorrhage: A narrative review
- Open Access
- 5 October 2025
- Published by Springer Nature in Research Square
Serum lipid levels predict mortality of aged patients in acute intracerebral hemorrhage
Background Intracerebral hemorrhage (ICH) carries high early mortality. Admission lipids have been linked to short-term outcomes, yet prior studies focused on conventional markers and rarely assessed age-specific effects. Because older adults often have lower nutritional reserve and higher medical complication rates, the prognostic value of lipids may be age dependent. We therefore evaluated a broader lipid profile to test their associations with 90-day mortality across different age group. Methods We conducted a single-center cohort at a tertiary academic hospital. Serum lipids, including total cholesterol(TC), triglycerides(TG), high-density lipoprotein cholesterol(HDL-C), low-density lipoprotein cholesterol(LDL-C), apolipoprotein A1(Apo A1), and apolipoprotein B(Apo B), were measured upon hospital admission. Patients were stratified as < 45 years and ≥ 45 years. Multivariate logistic regression was applied to investigate the associations between lipid levels, lipid ratios, and 90-day mortality. Discrimination was assessed using stratified 5-fold cross-validated single-marker receiver operating characteristic (ROC) analyses. Results We included 503 patients with acute ICH. In those older than 45 years, lower nonHDL-C (OR 0.898; 95%CI 0.814–0.990), Apo B (OR 0.861; 95%CI 0.748–0.990), nonHDL-C/HDL-C (OR 0.964; 95%CI 0.930–0.999), and Apo B/Apo A1 (OR 0.816; 95%CI 0.687–0.968) were independently associated with higher 90-day mortality. In ROC analyses, Apo B (AUC = 0.671) and Apo B/Apo A1 (AUC = 0.676) showed the highest discrimination among single markers, indicating modest predictive performance. Conclusion Lipid levels and ratios, particularly Apo B and Apo B/Apo A1, are independent predictors of 90-day mortality in middle-aged and older ICH patients, aiding clinical risk stratification.
- 5 October 2025
- Published by Springer Nature in Research Square
Open AccessSerum lipid levels predict mortality of aged patients in acute intracerebral hemorrhage
Background Intracerebral hemorrhage (ICH) carries high early mortality. Admission lipids have been linked to short-term outcomes, yet prior studies focused on conventional markers and rarely assessed age-specific effects. Because older adults often have lower nutritional reserve and higher medical complication rates, the prognostic value of lipids may be age dependent. We therefore evaluated a broader lipid profile to test their associations with 90-day mortality across different age group. Methods We conducted a single-center cohort at a tertiary academic hospital. Serum lipids, including total cholesterol(TC), triglycerides(TG), high-density lipoprotein cholesterol(HDL-C), low-density lipoprotein cholesterol(LDL-C), apolipoprotein A1(Apo A1), and apolipoprotein B(Apo B), were measured upon hospital admission. Patients were stratified as < 45 years and ≥ 45 years. Multivariate logistic regression was applied to investigate the associations between lipid levels, lipid ratios, and 90-day mortality. Discrimination was assessed using stratified 5-fold cross-validated single-marker receiver operating characteristic (ROC) analyses. Results We included 503 patients with acute ICH. In those older than 45 years, lower nonHDL-C (OR 0.898; 95%CI 0.814–0.990), Apo B (OR 0.861; 95%CI 0.748–0.990), nonHDL-C/HDL-C (OR 0.964; 95%CI 0.930–0.999), and Apo B/Apo A1 (OR 0.816; 95%CI 0.687–0.968) were independently associated with higher 90-day mortality. In ROC analyses, Apo B (AUC = 0.671) and Apo B/Apo A1 (AUC = 0.676) showed the highest discrimination among single markers, indicating modest predictive performance. Conclusion Lipid levels and ratios, particularly Apo B and Apo B/Apo A1, are independent predictors of 90-day mortality in middle-aged and older ICH patients, aiding clinical risk stratification.
- Open Access
Sephin1 alleviates white matter injury by protecting oligodendrocyte after intracerebral hemorrhage
Background: White matter injury (WMI) caused by intracerebral hemorrhage (ICH) is a major neuropathological feature closely associated with neurological impairments such as motor and sensory dysfunction. Oligodendrocytes (OLs), which are responsible for repairing WMI, also suffer severe death resulting from the compression of hematoma and secondary neuroinflammation after ICH. Sephin1, a selective inhibitor of PPP1R15A, has been shown to reduce general protein synthesis and protect OLs by prolonging the integrated stress response (ISR). We aimed to evaluate the effectiveness of Sephin1 in protecting OLs in experimental ICH mice and primary OLs and microglia co-cultures. Methods: We first determined the performance of ICH mice treated with Sephin1 or vehicle in multiple behavioral tests. To investigate dynamic changes in the number of OLs surrounding the hematoma after ICH, we labeled and tracked apoptotic, proliferating, and mature OLs using immunofluorescence staining. Results: Sephin1 treatment improved long-term neurological function after ICH, which was accompanied by a significant alleviation of WMI in the perihematomal region. Our data indicated that Sephin1 dramatically increased the population of OLs in the perihematomal region after ICH by inhibiting OL apoptosis and promoting OL proliferation. Moreover, Sephin1 treatment attenuated neuroinflammation after ICH by inhibiting microglial polarization to the M1 phenotype. In vitro , a co-culture model of primary OLs and microglia demonstrated that Sephin1 preserved the viability of OLs under pro-inflammatory conditions. Conclusions: Our observations suggest that Sephin1 is a promising therapeutic drug to preserve the OLs and alleviate WMI around the hematoma in ICH, highlighting its translational potential to improve long-term neurological recovery in hemorrhagic stroke.
Open AccessSephin1 alleviates white matter injury by protecting oligodendrocyte after intracerebral hemorrhage
Background: White matter injury (WMI) caused by intracerebral hemorrhage (ICH) is a major neuropathological feature closely associated with neurological impairments such as motor and sensory dysfunction. Oligodendrocytes (OLs), which are responsible for repairing WMI, also suffer severe death resulting from the compression of hematoma and secondary neuroinflammation after ICH. Sephin1, a selective inhibitor of PPP1R15A, has been shown to reduce general protein synthesis and protect OLs by prolonging the integrated stress response (ISR). We aimed to evaluate the effectiveness of Sephin1 in protecting OLs in experimental ICH mice and primary OLs and microglia co-cultures. Methods: We first determined the performance of ICH mice treated with Sephin1 or vehicle in multiple behavioral tests. To investigate dynamic changes in the number of OLs surrounding the hematoma after ICH, we labeled and tracked apoptotic, proliferating, and mature OLs using immunofluorescence staining. Results: Sephin1 treatment improved long-term neurological function after ICH, which was accompanied by a significant alleviation of WMI in the perihematomal region. Our data indicated that Sephin1 dramatically increased the population of OLs in the perihematomal region after ICH by inhibiting OL apoptosis and promoting OL proliferation. Moreover, Sephin1 treatment attenuated neuroinflammation after ICH by inhibiting microglial polarization to the M1 phenotype. In vitro , a co-culture model of primary OLs and microglia demonstrated that Sephin1 preserved the viability of OLs under pro-inflammatory conditions. Conclusions: Our observations suggest that Sephin1 is a promising therapeutic drug to preserve the OLs and alleviate WMI around the hematoma in ICH, highlighting its translational potential to improve long-term neurological recovery in hemorrhagic stroke.
- Open Access
- 10 April 2025
- Published by Elsevier in World Neurosurgery
- Vol. 198, 123971
Medical versus Surgical Treatment in Acute Intracerebral Hemorrhage: A Propensity-Matched Analysis
- 10 April 2025
- Published by Elsevier in World Neurosurgery
- Vol. 198, 123971
Open AccessMedical versus Surgical Treatment in Acute Intracerebral Hemorrhage: A Propensity-Matched Analysis
- 18 February 2025
- Published by S. Karger AG in Cerebrovascular Diseases
- p. 1-22
The prediction of hematoma growth in acute intracerebral hemorrhage: from 2-dimensional shape to 3-dimensional morphology
Introduction: The relationship between the 3-dimensional morphological features of hematoma and hematoma growth (HG) remains unclear. We aim to quantitatively assess the predictive value of 3-dimensional hematoma morphology for HG among patients with intracerebral hemorrhage (ICH). Methods: Our study comprised 312 consecutive ICH patients. Using semi-automated volumetric analysis software, we measured hematoma volumes and delineated the region of interest. We employed Python software to extract shape features, and receiver operating characteristic curve analysis to assess the predictive performance of hematoma morphology for HG. P value < 0.05 was considered statistically significant. Results: Sphericity and SurfaceArea emerged as the most effective 3-dimensional hematoma morphological predictors for HG. Optimal cutoff points relating to HG were Sphericity ≤ 0.56 and SurfaceArea > 55 cm2. We subsequently constructed the 3-dimensional morphology models, including the probability of hematoma morphology (PHM) and the probability of comprehensive model (PCM), to predict HG. The PHM model outperformed the irregular hematoma (p = 0.007), island sign (p = 0.032), and satellite sign (p < 0.001) in predictive accuracy for HG. Amongst all prediction models, the PCM presented the highest predictive value for active bleeding. Conclusions: The Sphericity≤0.56 and SurfaceArea >55 cm2 could represent the optimal threshold for HG prediction. PHM was considered a reliable 3-dimensional morphology model for HG prediction. PCM tended to be a better model for risk stratification of active bleeding in acute ICH patients.
- 18 February 2025
- Published by S. Karger AG in Cerebrovascular Diseases
- p. 1-22
The prediction of hematoma growth in acute intracerebral hemorrhage: from 2-dimensional shape to 3-dimensional morphology
Introduction: The relationship between the 3-dimensional morphological features of hematoma and hematoma growth (HG) remains unclear. We aim to quantitatively assess the predictive value of 3-dimensional hematoma morphology for HG among patients with intracerebral hemorrhage (ICH). Methods: Our study comprised 312 consecutive ICH patients. Using semi-automated volumetric analysis software, we measured hematoma volumes and delineated the region of interest. We employed Python software to extract shape features, and receiver operating characteristic curve analysis to assess the predictive performance of hematoma morphology for HG. P value < 0.05 was considered statistically significant. Results: Sphericity and SurfaceArea emerged as the most effective 3-dimensional hematoma morphological predictors for HG. Optimal cutoff points relating to HG were Sphericity ≤ 0.56 and SurfaceArea > 55 cm2. We subsequently constructed the 3-dimensional morphology models, including the probability of hematoma morphology (PHM) and the probability of comprehensive model (PCM), to predict HG. The PHM model outperformed the irregular hematoma (p = 0.007), island sign (p = 0.032), and satellite sign (p < 0.001) in predictive accuracy for HG. Amongst all prediction models, the PCM presented the highest predictive value for active bleeding. Conclusions: The Sphericity≤0.56 and SurfaceArea >55 cm2 could represent the optimal threshold for HG prediction. PHM was considered a reliable 3-dimensional morphology model for HG prediction. PCM tended to be a better model for risk stratification of active bleeding in acute ICH patients.
- 6 August 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 245, 108495
A comprehensive prediction model predicts perihematomal edema growth in the acute stage after intracerebral hemorrhage
- 6 August 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 245, 108495
A comprehensive prediction model predicts perihematomal edema growth in the acute stage after intracerebral hemorrhage
- 22 April 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (7) , 107731
Quantitative imaging for predicting hematoma expansion in intracerebral hemorrhage: A multimodel comparison
- 22 April 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (7) , 107731
Quantitative imaging for predicting hematoma expansion in intracerebral hemorrhage: A multimodel comparison
- Open Access
- 18 September 2023
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 30 (3)
SERPINA3: A novel inflammatory biomarker associated with cerebral small vessel disease burden in ischemic stroke
Background and Objective: Inflammation has emerged as a prominent risk factor for cerebral small vessel disease (CSVD). However, the specific association between various inflammatory biomarkers and the development of CSVD remains unclear. Serine proteinase inhibitor A3 (SERPINA3), Matrix metalloproteinase‐9 (MMP‐9), Tissue inhibitor metalloproteinase‐1 (TIMP‐1), Monocyte Chemoattractant Protein‐1 (MCP‐1) are several inflammatory biomarkers that are potentially involved in the development of CSVD. In this present study, we aimed to investigate the relationship between candidate molecules and CSVD features.Method: The concentration of each biomarker was measured in 79 acute ischemic stroke patients admitted within 72 h after symptom onset. The associations between blood levels of inflammatory markers and CSVD score were investigated, as well as each CSVD feature, including white matter hyperintensities (WMH), lacunes, and enlarged perivascular spaces (EPVS).Results: The mean age was 69.0 ± 11.8 years, and 65.8% of participants were male. Higher SERPINA3 level (>78.90 ng/mL) was significantly associated with larger WMH volume and higher scores on Fazekas's scale in all three models. Multiple regression analyses revealed the linear association between absolute WMH burden and SERPINA3 level, especially in model 3 (β = 0.14; 95% confidence interval [CI], 0.04–0.24p ). Restricted cubic spline regression demonstrated a dose–response relationship between SERPINA3 level and larger WMH volume (p nonlineariy = 0.0366 and 0.0378 in model 2 and mode 3, respectively). Using a receiving operating characteristic (ROC) curve, plasma SERPINA3 level of 64.15 ng/mL distinguished WMH >7.8 mL with the highest sensitivity and specificity (75.92% and 60%, respectively, area under curve [AUC] = 0.668, p = 0.0102). No statistically significant relationship has been found between other candidate biomarkers and CSVD features.Conclusion: In summary, among four inflammatory biomarkers that we investigated, SERPINA3 level at baseline was associated with WMH severity, which revealed a novel biomarker for CSVD and validated its relationship with inflammation and endothelial dysfunction.
- 18 September 2023
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 30 (3)
Open AccessSERPINA3: A novel inflammatory biomarker associated with cerebral small vessel disease burden in ischemic stroke
Background and Objective: Inflammation has emerged as a prominent risk factor for cerebral small vessel disease (CSVD). However, the specific association between various inflammatory biomarkers and the development of CSVD remains unclear. Serine proteinase inhibitor A3 (SERPINA3), Matrix metalloproteinase‐9 (MMP‐9), Tissue inhibitor metalloproteinase‐1 (TIMP‐1), Monocyte Chemoattractant Protein‐1 (MCP‐1) are several inflammatory biomarkers that are potentially involved in the development of CSVD. In this present study, we aimed to investigate the relationship between candidate molecules and CSVD features.Method: The concentration of each biomarker was measured in 79 acute ischemic stroke patients admitted within 72 h after symptom onset. The associations between blood levels of inflammatory markers and CSVD score were investigated, as well as each CSVD feature, including white matter hyperintensities (WMH), lacunes, and enlarged perivascular spaces (EPVS).Results: The mean age was 69.0 ± 11.8 years, and 65.8% of participants were male. Higher SERPINA3 level (>78.90 ng/mL) was significantly associated with larger WMH volume and higher scores on Fazekas's scale in all three models. Multiple regression analyses revealed the linear association between absolute WMH burden and SERPINA3 level, especially in model 3 (β = 0.14; 95% confidence interval [CI], 0.04–0.24p ). Restricted cubic spline regression demonstrated a dose–response relationship between SERPINA3 level and larger WMH volume (p nonlineariy = 0.0366 and 0.0378 in model 2 and mode 3, respectively). Using a receiving operating characteristic (ROC) curve, plasma SERPINA3 level of 64.15 ng/mL distinguished WMH >7.8 mL with the highest sensitivity and specificity (75.92% and 60%, respectively, area under curve [AUC] = 0.668, p = 0.0102). No statistically significant relationship has been found between other candidate biomarkers and CSVD features.Conclusion: In summary, among four inflammatory biomarkers that we investigated, SERPINA3 level at baseline was associated with WMH severity, which revealed a novel biomarker for CSVD and validated its relationship with inflammation and endothelial dysfunction.